Hemodialysis Market Will Reach USD 2206.7 Million By 2028 With A CAGR of 1.5% - Valuates Reports

The global Hemodialysis Market size is estimated to be worth USD 2018.1 million in 2022 and is forecast to be a readjusted size of USD 2206.7 million by 2028 with a CAGR of 1.5% during the review period.

MAJOR FACTORS DRIVING THE GROWTH OF THE HEMODIALYSIS MARKET

The global Hemodialysis Market is driven by rising cases of hypertension and diabetes. The increasing number of end-stage renal disorder (ESRD) patients and the shortage of kidney transplants are directly impacting the Hemodialysis Market trends.

The growing incidences of acute renal failure, drug poisoning, and at-home dialysis treatment will significantly boost the market in the coming years.

Browse The Table Of Contents And List Of Figures At https://reports.valuates.com/reports/QYRE-Auto-12M2358/covid-19-impact-on-global-hemodialysis

TRENDS INFLUENCING THE GROWTH OF THE HEMODIALYSIS MARKET

Acute renal failure affects a large portion of the global population every year. The retention of bodily waste products, electrolyte disturbances, and failure to clear out toxins from the blood can lead to significant clinical consequences. In most cases, kidney diseases do not show any symptoms. People who are hospitalized remain at high risk due to increased mortality. The experimental therapies include bioartificial kidneys or dialysis, vasoactive peptides, endothelin inhibitors, and adhesion molecules.

The Hemodialysis Market will grow rapidly due to rising chronic kidney diseases (CKD). CKD develops over a period of time leading to end-stage kidney or renal failure(ESRD). As per the Centers For Disease Control And Prevention about 15% of adults in the US or 37 million people suffer from CKD. The global burden for CKD and ESRD is only going to rise further thereby surging the demand for dialysis treatment to maintain proper kidney functioning.

Drug poisoning occurs from a variety of substances such as household products, industrial chemicals, plant, or animal derivatives, and pharmaceutical drugs. The most frequent dialyzed toxins remain alcohol, lithium, and salicylates. Hemodialysis remains the most effective treatment method in these cases. With technological advancements, efficacy has risen along with preventive healthcare methods. This in turn will boost the Hemodialysis Market Trends during the forecast period.

End-stage kidney failure patients require dialysis to remove impurities, wastes, and excess fluid from their bodies. They end up getting hooked to a dialysis machine for three to five hours a day. On top of that, the visit to an outpatient healthcare facility is time-consuming, causes exhaustion, itchy skin, and muscle cramps. Hence at-home hemodialysis machines are gaining traction as patients can control the place and timing of their treatment. Home dialysis also presents huge opportunities to people residing in rural regions who tend to avoid long commutes. These factors will surge the growth of the hemodialysis market in the subsequent years.

However, complications related to dialysis such as muscle cramps, lack of sleep, bone diseases, cardiac arrest, low pressure, hernia limit the uptake of the treatment which will hamper the market growth.

Get Your Sample Today:
https://reports.valuates.com/request/sample/QYRE-Auto-12M2358/Global_Hemodialysis_Market

HEMODIALYSIS MARKET SHARE ANALYSIS

Based on region, Europe is expected to lead with 42% in the Hemodialysis Market share followed by North America with 29%.

Inquire For Customization: https://reports.valuates.com/request/customisation/QYRE-Auto-12M2358/Global_Hemodialysis_Market

Market By Region

North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
Inquire For Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-12M2358/Global_Hemodialysis_Market

Market By Company

Fresenius
Baxter & Gambro
B.Braum
Nikkiso
Toray
Nipro
Bellco
Asahi Kasei
WEGO
Shanwaishan
Jihua
Inquire For Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-12M2358/Global_Hemodialysis_Marke

Buy Now for Single User + Covid-19 Impact : https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-12M2358&lic=single-user

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS

https://reports.valuates.com/reports/ALLI-Auto-2Z140/dialysis

https://reports.valuates.com/market-reports/QYRE-Auto-5K5506/global-dialysis-equipment

https://reports.valuates.com/market-reports/QYRE-Auto-26N416/global-peritoneal-dialysis

https://reports.valuates.com/market-reports/QYRE-Auto-19K6036/global-hemodialysis-access-graft

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.
Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

This release was published on openPR.